PHASE 1, OPEN-LABEL, DOSE-FINDING STUDY OF CC-90009, A NOVEL CEREBLON E3 LIGASE MODULATING DRUG, IN SUBJECTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

Type of Cancer
Head and Neck

Sponsor
Pfizer

Protocol Number
Pfized B9991016

To Learn More Call
(201)-510-0950